KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Common Equity (2016 - 2025)

Bausch Health Companies' Common Equity history spans 17 years, with the latest figure at -$554.0 million for Q4 2025.

  • For Q4 2025, Common Equity rose 56.68% year-over-year to -$554.0 million; the TTM value through Dec 2025 reached -$554.0 million, up 56.68%, while the annual FY2025 figure was -$554.0 million, 56.68% up from the prior year.
  • Common Equity for Q4 2025 was -$554.0 million at Bausch Health Companies, up from -$565.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $433.0 million in Q3 2022 and bottomed at -$1.3 billion in Q4 2024.
  • The 5-year median for Common Equity is -$138.0 million (2021), against an average of -$156.7 million.
  • The largest annual shift saw Common Equity soared 864.71% in 2022 before it plummeted 1459.76% in 2024.
  • A 5-year view of Common Equity shows it stood at -$34.0 million in 2021, then skyrocketed by 864.71% to $260.0 million in 2022, then crashed by 131.54% to -$82.0 million in 2023, then tumbled by 1459.76% to -$1.3 billion in 2024, then skyrocketed by 56.68% to -$554.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Common Equity are -$554.0 million (Q4 2025), -$565.0 million (Q3 2025), and $147.0 million (Q2 2025).